Morris Plains, NJ, United States of America

Radha Vippagunta

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Radha Vippagunta. Retrieved from https://idiyas.com/inventor/radha-vippagunta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Radha Vippagunta: Innovator in Vitamin E Formulations

Introduction

Radha Vippagunta is a notable inventor based in Morris Plains, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of Vitamin E formulations of sulfamide NS3 inhibitors. His work focuses on addressing HCV-associated disorders through innovative treatment methods.

Latest Patents

Radha Vippagunta holds 1 patent for his invention related to new formulations of compounds that exhibit activity against HCV-associated disorders. This patent encompasses new combinations, methods of treatment, and their therapeutic applications.

Career Highlights

Radha is currently employed at Novartis AG, a leading global healthcare company. His role involves research and development aimed at creating effective therapeutic solutions for viral infections.

Collaborations

Throughout his career, Radha has collaborated with talented individuals such as Sudhakar Devidasrao Garad and Anasuya Ashok Ghosh, who contribute to the innovative environment at Novartis AG.

Conclusion

Radha Vippagunta's work in the field of Vitamin E formulations represents a significant advancement in the treatment of HCV-associated disorders. His contributions continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…